Rosalind Advisors’s Cellectar Biosciences CLRB Stock Holding History

Rosalind Advisors’s Portfolio CLRB Stock Details CLRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$7.86M	Buy
2024 Q2	$6.76M	Buy
2024 Q1	$2.47M	Sell
2023 Q4	$5.56M	Buy